13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001515070
Total reported value
$635.1M
$635.1M
30 檔
50.4%
The Q1 2025 SEC filing reveals that Tetragon Partners GP Ltd held a total portfolio value of $635.1M, covering 30 public equity positions.
In Q1 2025, Tetragon Partners GP Ltd displayed an active expansion posture, initiating 30 new positions and adding to 0 existing holdings, outstripping position reductions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | HYG | Ishr Ibx Usd Hiyld Cb Etf-ui | ETF-High Yield | 29.98% | — | +53.87% | |
| 2 | PATH | Uipath Inc - Class A | Stock-Tech | 21.04% | -1.34% | +28.78% | |
| 3 | KGEI | Kolibri Global Energy Inc | Stock-Other | 13.47% | -1.95% | — | |
| 4 | LARCN 1.75 01-15-27Bond | Lithium Argentina AG | Bond | 4.41% | — | -9.69% | |
| 5 | CXM | Sprinklr Inc-a | Stock-Other | 4.19% | -0.77% | — | |
| 6 | AGCN 0.375 01-15-27Bond | First Majestic Silver | Bond | 3.56% | — | +6.45% | |
| 7 | INFA1EUR | Informatica Inc - Class A | Stock-Other | 3.19% | — | +33.33% | |
| 8 | AUTL | Autolus Therapeutics PLC | Stock-Other | 3.04% | -0.16% | +4.24% | |
| 9 | OTLY 9.25 09-14-28Bond | Oatly Group AB | Bond | 2.84% | — | — | |
| 10 | LYFT | Lyft Inc-a | Stock-Tech | 2.71% | -0.28% | — | |
| 11 | TARS | Tarsus Pharmaceuticals Inc | Stock-Other | 2.09% | — | -10.77% | |
| 12 | CYTK 3.5 07-01-27Bond | Cytokinetics Inc | Bond | 1.32% | — | -16.67% | |
| 13 | ANNX | Annexon Inc | Stock-Other | 1.17% | -0.27% | +89.29% | |
| 14 | CLDX | Celldex Therapeutics Inc | Stock-Other | 1.08% | -0.22% | +35.94% | |
| 15 | SSRMCN 2.5 04-01-39Bond | Ssr Mining Inc | Bond | 0.93% | — | -80.00% | |
| 16 | AXSM | Axsome Therapeutics Inc | Stock-Healthcare | 0.90% | -0.46% | -18.05% | |
| 17 | TECX | Tectonic Therapeutic Inc | Stock-Other | 0.76% | +0.02% | — | |
| 18 | IMVT | Immunovant Inc | Stock-Other | 0.51% | +0.50% | — | |
| 19 | PHVS | Pharvaris N.V. | Stock-Other | 0.46% | +0.39% | — | |
| 20 | KROS | Keros Therapeutics Inc | Stock-Other | 0.43% | — | +77.67% | |
| 21 | ACAD | Acadia Pharmaceuticals Inc | Stock-Healthcare | 0.41% | +0.05% | — | |
| 22 | RLAY | Relay Therapeutics Inc | Stock-Other | 0.37% | +1.33% | — | |
| 23 | SNOW | Snowflake Inc | Stock-Tech | 0.33% | +0.11% | — | |
| 24 | CCJ | Cameco CORP | Stock-Energy | 0.20% | — | — | |
| 25 | BVN | Cia De Minas Buenaventur-adr | Stock-Other | 0.20% | — | +50.00% | |
| 26 | HBM | Hudbay Minerals Inc | Stock-Other | 0.19% | — | +84.48% | |
| 27 | OTLY | Oatly Group AB | Stock-Other | 0.18% | — | — | |
| 28 | TECK | Teck Resources Ltd-cls B | Stock-Materials | 0.05% | — | — | |
| 29 | ✓ | Diana Shipping Inc | Stock-Other | 0.01% | — | — | |
| 30 | SONWQ | Gores Metropoulos Ii -cw28 | Stock-Other | — | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | HYG | Ishr Ibx Usd Hiyld Cb Etf-ui | — | NEW | New buy |
| 2 | PATH | Uipath Inc - Class A | — | NEW | New buy |
| 3 | KGEI | Kolibri Global Energy Inc | — | NEW | New buy |
| 4 | LARCN 1.75 01-15-27Bond | Lithium Argentina AG | — | NEW | New buy |
| 5 | CXM | Sprinklr Inc-a | — | NEW | New buy |
| 6 | AGCN 0.375 01-15-27Bond | First Majestic Silver | — | NEW | New buy |
| 7 | INFA1EUR | Informatica Inc - Class A | — | NEW | New buy |
| 8 | AUTL | Autolus Therapeutics PLC | — | NEW | New buy |
| 9 | OTLY 9.25 09-14-28Bond | Oatly Group AB | — | NEW | New buy |
| 10 | LYFT | Lyft Inc-a | — | NEW | New buy |
| 11 | TARS | Tarsus Pharmaceuticals Inc | — | NEW | New buy |
| 12 | CYTK 3.5 07-01-27Bond | Cytokinetics Inc | — | NEW | New buy |
| 13 | ANNX | Annexon Inc | — | NEW | New buy |
| 14 | CLDX | Celldex Therapeutics Inc | — | NEW | New buy |
| 15 | SSRMCN 2.5 04-01-39Bond | Ssr Mining Inc | — | NEW | New buy |
| 16 | AXSM | Axsome Therapeutics Inc | — | NEW | New buy |
| 17 | TECX | Tectonic Therapeutic Inc | — | NEW | New buy |
| 18 | IMVT | Immunovant Inc | — | NEW | New buy |
| 19 | PHVS | Pharvaris N.V. | — | NEW | New buy |
| 20 | KROS | Keros Therapeutics Inc | — | NEW | New buy |
| 21 | ACAD | Acadia Pharmaceuticals Inc | — | NEW | New buy |
| 22 | RLAY | Relay Therapeutics Inc | — | NEW | New buy |
| 23 | SNOW | Snowflake Inc | — | NEW | New buy |
| 24 | CCJ | Cameco CORP | — | NEW | New buy |
| 25 | BVN | Cia De Minas Buenaventur-adr | — | NEW | New buy |
| 26 | HBM | Hudbay Minerals Inc | — | NEW | New buy |
| 27 | OTLY | Oatly Group AB | — | NEW | New buy |
| 28 | TECK | Teck Resources Ltd-cls B | — | NEW | New buy |
| 29 | ✓ | Diana Shipping Inc | — | NEW | New buy |
| 30 | SONWQ | Gores Metropoulos Ii -cw28 | — | NEW | New buy |
According to official SEC Form 13F filings, Tetragon Partners GP Ltd reported a total U.S. public equity portfolio value of $635.1M across 30 disclosed positions in Q1 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including HYG, PATH, KGEI) accounted for 50.4% of total reported equity market value during Q1 2025.
Top New Position Initiated
HYG
市值: $131.4M
During Q1 2025, Tetragon Partners GP Ltd's top holdings by market value included HYG (30.0%)、PATH (21.0%)、KGEI (13.5%). The largest single position, HYG, represented 30.0% of total portfolio value.
In Q1 2025, Tetragon Partners GP Ltd made 30 total portfolio adjustments, initiating 30 new buys, adding to 0 positions, trimming 0 holdings, and fully liquidating 0 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.